NCT00993837

Brief Summary

Endoscopic thyroidectomy has been used to treat thyroid diseases in China. However, whether this technique is rational to treat thyroid carcinoma is still in controversy. The diagnosis of thyroid carcinoma is predominantly made according to intra-operative frozen section pathological examination in China. In this research, the investigators want to compare clinical index (blood loss, operation duration, number of lymph nodes dissected, complication rates, etc) between patients underwent endoscopic thyroidectomy ( total thyroidectomy) and those underwent conversion to open procedure. The investigators want to evaluate the technical feasibility of endoscopic thyroidectomy for treating thyroid carcinoma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2009

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 14, 2009

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

October 14, 2009

Status Verified

October 1, 2009

Enrollment Period

1.9 years

First QC Date

September 29, 2009

Last Update Submit

October 13, 2009

Conditions

Keywords

endoscopic thyroidectomythyroid carcinoma

Outcome Measures

Primary Outcomes (1)

  • to evaluate the completeness of thyroid resection and clearance of lymph nodes in the central compartment, and to observe the complications such as RLN palsy and hypocalcemia

    1 year after operation

Study Arms (1)

conversion

EXPERIMENTAL
Procedure: thyroidectomy

Interventions

thyroidectomyPROCEDURE

total thyroidectomy via endoscopic approach and that convert to open procedure

Also known as: totally endoscopic thyroidectomy
conversion

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • lesion diameter less than 1 cm by ultrasound

You may not qualify if:

  • frozen section diagnosis indicates benign lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changzheng Hospital

Shanghai, Shanghai Municipality, 200003, China

Location

MeSH Terms

Conditions

Thyroid Neoplasms

Interventions

Thyroidectomy

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Intervention Hierarchy (Ancestors)

Endocrine Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Ming QIU, Dr.

    Changzheng Hospital affliated to SMMU

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 29, 2009

First Posted

October 14, 2009

Study Start

January 1, 2010

Primary Completion

December 1, 2011

Study Completion

June 1, 2012

Last Updated

October 14, 2009

Record last verified: 2009-10

Locations